Author: Barbara McGovern
Publisher: Elsevier Health Sciences
ISBN: 145574719X
Category : Medical
Languages : en
Pages : 240
Get Book
Book Description
Hepatitis C infection can be an acute or chronic illness and is the most common cause of liver disease in the US. It often goes undiagnosed until significant organ damage has occurred. This issue of the ID Clinics discusses the staging of liver disease, treatments for those newly diagnosed, and those who are dealing with chronic illness, along with managing drug therapy and virus resistance.
Author: Barbara McGovern
Publisher: Saunders
ISBN: 9781455748990
Category : Medical
Languages : en
Pages : 0
Get Book
Book Description
Hepatitis C infection can be an acute or chronic illness and is the most common cause of liver disease in the US. It often goes undiagnosed until significant organ damage has occurred. This issue of the ID Clinics discusses the staging of liver disease, treatments for those newly diagnosed, and those who are dealing with chronic illness, along with managing drug therapy and virus resistance.
Author: Bandar Al Knawy
Publisher: Elsevier Health Sciences
ISBN: 1455700401
Category : Medical
Languages : en
Pages : 193
Get Book
Book Description
This issue offers the latest information regarding the transmission of hepatitis viruses in various healthcare settings. It delves with a very timely and interesting patient safety subject that specifically targets healthcare professionals, gastroenterologists, hepatologists, oncologists, dentists and all healthcare workers to adopt and share a variety of best practices to prevent this adverse event. Well known faculty in liver disease, infection control as well as a medical practice in a legal setting have been assembled to produce a comprehensive and concise edition that highlights the latest information regarding hepatitis B and C transmission in healthcare. It aims to provide an overview on the molecular epidemiology, the outbreak reports, the transmission in hemodialysis, endoscopy, dental, oncology, management, legal aspects and the infection prevention measures to reduce the risk of needless exposure of patients to these blood borne pathogens.
Author: Fred Poordad
Publisher: Elsevier Health Sciences
ISBN: 0323413374
Category : Medical
Languages : en
Pages :
Get Book
Book Description
Clinical information about Hepatitis C is quickly outdated, so Dr. Poordad has assembled expert authors to provide state-of-the-art clinjcal reviews for hepatologists. This issue is uniquely organized to present articles based on therapeutic regimens for certain types of patients: Regimens for the Treatment-Naïve Patient; Regimens for Treatment of the Interferon-Failure Patient; Regimens for DAA Failure Patients; Regimens for the Cirrhotic Patient; Regimens for the Peri-Transplant Patient; Regimens for the HIV-Co-Infected Patient; and Next-generation Regimens: The Future of HCV Therapy. This presentation will be very clinically relevant for the practicing hepatologist.
Author: Keith S. Kaye
Publisher: Elsevier Health Sciences
ISBN: 0323835171
Category : Medical
Languages : en
Pages : 329
Get Book
Book Description
Infection Prevention and Control in Healthcare, Part I: Facility Planning, An Issue of Infectious Disease Clinics of North America, E-Book
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309438020
Category : Medical
Languages : en
Pages : 187
Get Book
Book Description
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report.
Author: John E Bennett
Publisher: Elsevier
ISBN: 9780323428033
Category :
Languages : en
Pages : 107
Get Book
Book Description
"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases Latest Developments in Hepatitis C" "with accompanying Clinics Review Articles" details the newest late-breaking approvals, recommendations, and key content on the treatment of hepatitis C in a convenient eBook-only format. Brought to you by the expert editor team from Principles and Practice of Infectious Diseases, it provides the most current research and findings related to newly approved antivirals, guidelines for treatments, and clinical experiences with new HCV therapeutic regimens. In addition to this extended content, you'll also receive two accompanying Clinics Review Articles for further information on the management of the virus in women and patients with chronic liver disease.
Author: Camilla S. Graham
Publisher: Elsevier Health Sciences
ISBN: 0323584047
Category : Medical
Languages : en
Pages : 265
Get Book
Book Description
The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analysis of solutions to specific challenges faced in the United States and globally in implementing HCV elimination strategies. They believe that clinicians now have the tools and road maps needed to accomplish this goal. The clinical review articles in this issue accomplish that: Using Existing Health Care Infrastructure To Expand HCV Care; Creating A Reproducible Health Economic Model To Describe The Burden Of HCV And Cost Of Treatment In Any Country; The Best Uses Of Cost-Effectiveness Models In HCV; Increasing Access To HCV Care In Corrections; Cure As Prevention Strategies For HCV In People Who Inject Drugs; Australia Will Eliminate HCV – How It Works; New York Is The First State In The US To Develop An HCV Elimination Strategy; When HCV Diagnostics Are The Barrier To Care; Key Findings From The Checs HCV Cohort Study; Strategies To Reduce HCV Reinfection Rates In People Who Inject Drugs; Strategies To Reduce HCV Reinfection Rates In Men Who Have Sex With Other Men; The Value Of Curing HCV From A Payer’s Perspective; How To Expand Care Capacity In HCV; Strategies To Eliminate HCV In The HIV Coinfected Population; and The US Veteran’s Administration: Lessons Learned And Best Practices For HCV Elimination.
Author: Keith S. Kaye
Publisher: Elsevier Health Sciences
ISBN: 0323813704
Category : Medical
Languages : en
Pages : 273
Get Book
Book Description
Infection Prevention and Control in Healthcare, Part II: Clinical Management of Infections, An Issue of Infectious Disease Clinics of North America, E-Book
Author: Paul J. Pockros
Publisher: Elsevier Health Sciences
ISBN: 1455771988
Category : Medical
Languages : en
Pages : 245
Get Book
Book Description
Dr. Pockros has created a clinically focused issue based on the CONO 2012 meeting, whereby he was able to have those presenters write articles for his issue. Therefore, the content for HCV in this issue reflects the most current knowledge. The issue is focused on basic/current information, current therapy and special populations, triple and quad combination therapies in development, and an article on second generation protease inhibitors. The reader can expect that this issue will provide thorough clinical reviews on the most current therapeutic options for HCV.
